Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Retroviral Vector Mediated Globin Gene Transfer to Correct Sickle Cell Anemia or Thalassemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by St. Jude Children's Research Hospital
Sponsor:
Collaborators:
Assisi Foundation
Doris Duke Charitable Foundation
University of Tennessee
Information provided by (Responsible Party):
St. Jude Children's Research Hospital
ClinicalTrials.gov Identifier:
NCT00669305
First received: April 28, 2008
Last updated: December 22, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2018
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)